Home > Journals > Medicine > Bulletin du cancer > Full text
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
Bulletin du Cancer
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
  Printable version
  Version PDF

Long term hematologic recovery after autologous stem cell transplantation in lymphoma patients: impact of the number of prefreeze and post-thaw CD34+ cells


Bulletin du Cancer. Volume 92, Number 3, 10031-8, Mars 2005, Electronic journal of oncology


Summary  

Author(s) : Nicolas Mounier, Jérome Larghero, Julien Manson, Pauline Brice, Isabelle Madelaine-Chambrin, Josette Brière, Marjane Ertault, Christophe Hennequin, Jean-Michel Miclea, Marc Benbunan, Jean-Pierre Marolleau, Christian Gisselbrecht , Institut universitaire d’hématologie, Hôpital Saint-Louis, Inserm ERM 0220, 1, avenue Claude-Vellefaux, 75010 Paris, France.

Summary : Background. – Autologous Stem Cell Transplantation (ASCT) with Peripheral Blood Stem Cells is widely used as consolidation in lymphoma patients. The rapidity and stability of cell engraftment correlate with the number of CD34+ cells in the autograft. However, whether CD34+ cells should be quantified before or after cryopreservation remains unclear. Patients and methods. – Of 173 consecutive patients who underwent ASCT in our department from Nov 1, 1995 to Nov 1, 2000, 133 (78 %) were alive without relapse at one year. We report here the results for 106 patients whose hematologic data were available. Results. – At one year, the hemoglobin was normal in 47 % of the patients, the leukocytes, in 77 % and the platelets, in 60 %. Only 33 % had a normal blood count. We observed a significant correlation between prefreeze and post-thaw CD34+ cell numbers (r \= 0.77). However, multivariate analysis using the Cox model with smoothing splines to assess the best cut-off point for these numbers demonstrated that the only independent predictive factor for a normal blood count after one year was a prefreeze number of CD34+ cells above 5.10 6/kg. Conclusion. – An optimal long-term hematologic recovery after ASCT required a number of prefreeze CD34+ cells of at least 5.10 6/kg.

Keywords : peripheral blood stem cell transplantation, CD34+ cells, cryopreservation, prognostic factors

Pictures

Figure 1 Plot of prefreeze and post-thaw numbers of CD34+ cells (r = 0.77) in lymphoma patients. Dotted line shows the perfect correlation.

Figure 2 Engraftment of PBSC in lymphoma patients : relative risk (RR) of granulocytes > 0.5 G/L according to prefreeze CD34+ cell number. Spline curve show how the RR changes with the number of CD34+ cells. Dotted lines show the 95 % confidence interval. Bold lines show the best cut-off point.

Figure 3 Normal blood counts in lymphoma patients at one year after ASCT : relative risk (RR) of normal blood count according to prefreeze CD34+ cell number (A) and post-thaw CD34+ cell number (B). Spline curves show how the RR changes with the number of CD34+ cells. Dotted lines shows the 95 % confidence interval. Bold lines show the best cut-off point.


 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]